
Opinion|Videos|June 2, 2025
Early Detection of ccRCC
Panelists discuss how deep learning applied to imaging data sets may advance kidney cancer assessment, though they believe the next major leap will require true molecular imaging that reveals what tumors are expressing.
Advertisement
Episodes in this series

Future Directions for Imaging in Kidney Cancer
Main Discussion Topics:
- Potential for deep learning and artificial intelligence (AI) to extract additional information from imaging data sets
- Recognition that computational approaches have limitations
- The future likely requires molecular imaging that assesses tumor expression patterns.
Key Points for Physicians:
- AI and deep learning may identify imaging features not apparent to human readers.
- Computational approaches alone may have limitations.
- Molecular imaging represents the next frontier in renal mass characterization.
Notable Insights:
Although AI approaches show promise, the experts believe the most significant advances will come from molecular imaging techniques that directly assess tumor biology.
Clinical Significance:
Combination of computational approaches and molecular imaging will likely provide the next major advance in renal mass characterization.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











